A Randomized Phase Ii Trial of Ridaforolimus, Dalotuzumab, and Exemestane Compared with Ridaforolimus and Exemestane in Patients with Advanced Breast Cancer

AuthID
 P-00N-1B3
20
Author(s)
Tredan, O
·
Ro, J
·
Morales, SM
·
Campone, M
·
Musolino, A
·
Afonso, N
·
Ferreira, M
·
Park, KH
·
Cortes, J
·
Tan, AR
·
Blum, JL
·
Eaton, L
·
Gause, CK
·
Wang, Z
·
Im, E
·
Mauro, DJ
·
Jones, MB
·
Denker, A
·
Baselga, J
Document Type
Article
Year published
2017
Published
in BREAST CANCER RESEARCH AND TREATMENT, ISSN: 0167-6806
Volume: 165, Issue: 3, Pages: 601-609 (9)
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000411105800015
Source Identifiers
ISSN: 0167-6806
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service